Amgen
AMGN
$262.75
Share price
-0.50%
Change (1 day)
6.77%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $90.92 B
According to Amgen's latest financial reports the company's total liabilities are $90.92 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Amgen - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $90.92 B | 47.94% |
| 2022-12-31 | $61.46 B | 12.84% |
| 2021-12-31 | $54.46 B | 1.73% |
| 2020-12-31 | $53.53 B | 7.01% |
| 2019-12-31 | $50.03 B | -7.2% |
| 2018-12-31 | $53.91 B | -1.46% |
| 2017-12-31 | $54.71 B | 14.58% |
| 2016-12-31 | $47.75 B | 10.11% |
| 2015-12-31 | $43.36 B | 0.31% |
| 2014-12-31 | $43.23 B | -1.81% |
| 2013-12-31 | $44.02 B | 24.95% |
| 2012-12-31 | $35.23 B | 18.08% |
| 2011-12-31 | $29.84 B | 52.71% |
| 2010-12-31 | $19.54 B | 15.21% |
| 2009-12-31 | $16.96 B | 5.64% |
| 2008-12-31 | $16.05 B | -4.25% |
| 2007-12-31 | $16.77 B | 13.13% |
| 2006-12-31 | $14.82 B | 67.58% |
| 2005-12-31 | $8.84 B | -7.04% |
| 2004-12-31 | $9.51 B | 41.52% |
| 2003-12-31 | $6.72 B | 8.98% |
| 2002-12-31 | $6.17 B | 403.3% |
| 2001-12-31 | $1.22 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 8.65% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 50.91% | 🇺🇸 USA |
 AbbVie ABBV | $124.31 B | 36.73% | 🇺🇸 USA |
 Eli Lilly LLY | $53.14 B | -41.55% | 🇺🇸 USA |
 Biogen BIIB | $12.04 B | -86.75% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | -56.69% | 🇺🇸 USA |
 Illumina ILMN | $4.36 B | -95.20% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | -27.77% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | -35.30% | 🇬🇧 UK |